We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NIVFW
9376
NewGenIvf Group Warrants
NIVFW
$2 ﹤0.01%
+82
New +$4
BLACR
9377
DELISTED
Bellevue Life Sciences Acquisition Corp. Rights
BLACR
$2 ﹤0.01%
22
PLAOW
9378
DELISTED
Patria Latin American Opportunity Acquisition Corp. Warrant
PLAOW
$2 ﹤0.01%
+30
New +$2
ABLVW icon
9379
Able View Global Warrant
ABLVW
$136K
$1 ﹤0.01%
+36
New +$2
BOWNR
9380
DELISTED
Bowen Acquisition Corp Rights
BOWNR
$1 ﹤0.01%
12
-3
-20%
CELG.RT
9381
Bristol-Myers Squibb Rights
CELG.RT
$191M
$1 ﹤0.01%
31
+1
+3%
CNET icon
9382
ZW Data Action Technologies
CNET
$5.87M
0
ITRM
9383
DELISTED
Iterum Therapeutics
ITRM
$1 ﹤0.01%
1
-12,018
-100% -$17.4K
RCKTW icon
9384
Rocket Pharmaceuticals Warrant
RCKTW
$149K
$1 ﹤0.01%
24
-75
-76% -$9
RVSNW icon
9385
Rail Vision Ltd Warrant
RVSNW
$816K
$1 ﹤0.01%
+12
New +$1
RTB
9386
RTB Digital
RTB
$214M
-191
Closed -$10.8K
SLE icon
9387
Super League Enterprise
SLE
$4.28M
-7
Closed -$4.5K
SVIIR
9388
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$1 ﹤0.01%
+9
New +$1
TOVX icon
9389
Theriva Biologics
TOVX
$9.64M
0
UNCY icon
9390
Unicycive Therapeutics
UNCY
$137M
-439
Closed -$4.32K
PBMWW
9391
Psyence Biomedical Warrant
PBMWW
$450K
$1 ﹤0.01%
73
VINC
9392
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
-125
Closed -$3.14K
NMHIW
9393
DELISTED
Natures Miracle Holding Inc. Warrants
NMHIW
$1 ﹤0.01%
40
PFTAW
9394
DELISTED
Perception Capital Corp. III Warrant
PFTAW
$1 ﹤0.01%
50
LUXH
9395
DELISTED
LuxUrban Hotels Inc. Common Stock
LUXH
-57
Closed -$2.54K
AEAEW
9396
DELISTED
AltEnergy Acquisition Corp Warrant
AEAEW
$1 ﹤0.01%
+46
New +$2
ONYXW
9397
DELISTED
Onyx Acquisition Co. I Warrant
ONYXW
$1 ﹤0.01%
+46
New +$1
PRSTW
9398
DELISTED
Presto Technologies, Inc. Warrant
PRSTW
$1 ﹤0.01%
28
-61,193
-100% -$1.18K
NSTB.WS
9399
DELISTED
Northern Star Investment Corp. II Redeemable warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTB.WS
$1 ﹤0.01%
133
MTEM
9400
DELISTED
Molecular Templates, Inc.
MTEM
$1 ﹤0.01%
1
-5,190
-100% -$7.69K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.